Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 3953 questions Show Answers
To ask the Scottish Government what its response is to the concerns that have been raised by the mental health charity, Miricyl, that a relatively small share of funding is allocated to mental health research compared with that for physical health.
To ask the Scottish Government whether it will publish data showing how many obese people there have been in (a) Scotland and (b) each NHS board area in each of the last five calendar years, broken down by (i) age and (ii) gender.
To ask the Scottish Government what plans it has to introduce and implement a national obesity strategy for adults and children, and what discussions (a) ministers and (b) its officials have had on the issue since January 2014.
To ask the Scottish Government whether it will provide an update regarding how many sanitary products have been delivered to (a) hospitals, (b) schools, (c) colleges and (d) universities to be distributed for free.
To ask the Scottish Government what steps it is taking to reduce disparities in levels of (a) adult and (b) childhood obesity on the basis of deprivation.
To ask the Scottish Government (a) how many and (b) what percentage of newborns have received a baby box each year.
To ask the Scottish Government what plans it has to publish details regarding the process for agreeing commercial and data collection arrangements for medicines that are subject to the new ultra-orphan pathway.
To ask the Scottish Government how real world evidence will be used following the interim funding period as part of the assessment of medicines subject to the new ultra-orphan pathway.
To ask the Scottish Government when it will publish details of the process for agreeing commercial and data collection arrangements for medicines subject to the new ultra-orphan pathway.
To ask the Scottish Government what framework will be used following the interim funding period to assess medicines subject to the new ultra-orphan pathway.